<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Chang HY</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Guideline-directed medical therapy (GDMT) improves outcomes in heart failure with reduced ejection fraction, yet its adoption across Asia remains suboptimal. The American Heart Association launched the GWTG-HF A.S.I.A. (Get With The Guidelines-Heart Failure Adherence to Science, Implementation in Asia) program in 2021. We examined the association between program participation and GDMT implementation in Taiwan.&lt;h4>Methods&lt;/h4>We analyzed 1991 patients with heart failure with reduced ejection fraction enrolled in the Taiwan Society of Cardiology HF Registry (2021-2024). Four hospitals participated in the GWTG-HF A.S.I.A. program (n=462) and 23 nonparticipating hospitals served as controls (n=1529). After propensity-score matching, prescription trends of 4-pillar GDMTs were</pubmed_abstract><journal>Journal of the American Heart Association</journal><pagination>e047097</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12909023</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Implementation of the Get With The Guidelines-Heart Failure Adherence to Science, Implementation in Asia (GWTG-HF A.S.I.A.) Program in Taiwan.</pubmed_title><pmcid>PMC12909023</pmcid><pubmed_authors>Allen LA</pubmed_authors><pubmed_authors>Sung SH</pubmed_authors><pubmed_authors>Chang HY</pubmed_authors><pubmed_authors>Liao CT</pubmed_authors><pubmed_authors>Heidenreich PA</pubmed_authors><pubmed_authors>Huang N</pubmed_authors><pubmed_authors>Hsu CY</pubmed_authors><pubmed_authors>Wang TD</pubmed_authors><pubmed_authors>Li YH</pubmed_authors><pubmed_authors>Chen WJ</pubmed_authors><pubmed_authors>Wu YW</pubmed_authors></additional><is_claimable>false</is_claimable><name>Implementation of the Get With The Guidelines-Heart Failure Adherence to Science, Implementation in Asia (GWTG-HF A.S.I.A.) Program in Taiwan.</name><description>&lt;h4>Background&lt;/h4>Guideline-directed medical therapy (GDMT) improves outcomes in heart failure with reduced ejection fraction, yet its adoption across Asia remains suboptimal. The American Heart Association launched the GWTG-HF A.S.I.A. (Get With The Guidelines-Heart Failure Adherence to Science, Implementation in Asia) program in 2021. We examined the association between program participation and GDMT implementation in Taiwan.&lt;h4>Methods&lt;/h4>We analyzed 1991 patients with heart failure with reduced ejection fraction enrolled in the Taiwan Society of Cardiology HF Registry (2021-2024). Four hospitals participated in the GWTG-HF A.S.I.A. program (n=462) and 23 nonparticipating hospitals served as controls (n=1529). After propensity-score matching, prescription trends of 4-pillar GDMTs were</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-15T16:26:43.185Z</modification><creation>2026-07-07T03:07:26.142Z</creation></dates><accession>S-EPMC12909023</accession><cross_references><pubmed>41413759</pubmed><doi>10.1161/JAHA.125.047097</doi></cross_references></HashMap>